StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Let’s be honest

<< Previous

Bullboard Posts

Next >>

Post by brad129on Dec 02, 2020 7:53pm

492 Views

Post# 32023389

Let’s be honest

People on here talking about $1 that is a complete joke, we were at .20 preconsolidation prior to any COVID, that is $1.60 today, we got there with basically speculation on colonSentry, with COVID testing and real revenue, add i. Aristotle on the horizon $1 is a complete joke. 5-10 would be more in line for what we have going on.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China